Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study
Sonia Zaibet, Vincent Hautefeuille, Édouard Auclin, Astrid Lièvre, David Tougeron, Matthieu Sarabi, Marine Gilabert, Julie Wasselin, Julien Edeline, Pascal Artru, Dominique Béchade, Clémence Morin, Agnès Ducoulombier, Julien Taı̈eb, Simon Pernot
Topics & Concepts
FOLFIRINOXGemcitabineMedicineInternal medicineGastroenterologyAdenocarcinomaToxicityPaclitaxelOncologyProgression-free survivalPancreatic cancerSurgeryChemotherapyIrinotecanCancerColorectal cancerPancreatic and Hepatic Oncology ResearchRenal cell carcinoma treatmentIntraperitoneal and Appendiceal Malignancies